BDX * Stock Overview
Develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 4/6 |
Becton, Dickinson and Company Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$4,400.00 |
52 Week High | US$4,775.68 |
52 Week Low | US$3,764.15 |
Beta | 0.45 |
11 Month Change | -7.87% |
3 Month Change | -3.14% |
1 Year Change | n/a |
33 Year Change | -14.94% |
5 Year Change | -12.82% |
Change since IPO | -2.09% |
Recent News & Updates
Recent updates
Shareholder Returns
BDX * | MX Medical Equipment | MX Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how BDX * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how BDX * performed against the MX Market.
Price Volatility
BDX * volatility | |
---|---|
BDX * Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in MX Market | 0% |
10% least volatile stocks in MX Market | 0% |
Stable Share Price: BDX *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine BDX *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1897 | 73,000 | Tom Polen | www.bd.com |
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems.
Becton, Dickinson and Company Fundamentals Summary
BDX * fundamental statistics | |
---|---|
Market cap | Mex$1.33t |
Earnings (TTM) | Mex$29.88b |
Revenue (TTM) | Mex$406.09b |
44.4x
P/E Ratio3.3x
P/S RatioIs BDX * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BDX * income statement (TTM) | |
---|---|
Revenue | US$19.83b |
Cost of Revenue | US$10.93b |
Gross Profit | US$8.90b |
Other Expenses | US$7.44b |
Earnings | US$1.46b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 06, 2025
Earnings per share (EPS) | 5.05 |
Gross Margin | 44.90% |
Net Profit Margin | 7.36% |
Debt/Equity Ratio | 74.7% |
How did BDX * perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield75%
Payout RatioDoes BDX * pay a reliable dividends?
See BDX * dividend history and benchmarksBecton Dickinson dividend dates | |
---|---|
Ex Dividend Date | Dec 09 2024 |
Dividend Pay Date | Dec 31 2024 |
Days until Ex dividend | 14 days |
Days until Dividend pay date | 36 days |
Does BDX * pay a reliable dividends?
See BDX * dividend history and benchmarks